358 related articles for article (PubMed ID: 11753600)
1. Long-term follow-up of patients with newly diagnosed adult acute lymphoblastic leukemia: a single institution experience of 378 consecutive patients over a 21-year period.
Thomas X; Danaïla C; Le QH; Sebban C; Troncy J; Charrin C; Lhéritier V; Michallet M; Magaud JP; Fiere D
Leukemia; 2001 Dec; 15(12):1811-22. PubMed ID: 11753600
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow biopsy in adult acute lymphoblastic leukemia: morphological characteristics and contribution to the study of prognostic factors.
Thomas X; Le QH; Danaïla C; Lhéritier V; Ffrench M
Leuk Res; 2002 Oct; 26(10):909-18. PubMed ID: 12163052
[TBL] [Abstract][Full Text] [Related]
3. Acute lymphoblastic leukemia in the elderly: The Edouard Herriot Hospital experience.
Thomas X; Olteanu N; Charrin C; Lhéritier V; Magaud JP; Fiere D
Am J Hematol; 2001 Jun; 67(2):73-83. PubMed ID: 11343378
[TBL] [Abstract][Full Text] [Related]
4. Allogeneic Stem Cell Transplantation versus Tyrosine Kinase Inhibitors Combined with Chemotherapy in Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia.
Wang J; Jiang Q; Xu LP; Zhang XH; Chen H; Qin YZ; Ruan GR; Jiang H; Jia JS; Zhao T; Liu KY; Jiang B; Huang XJ
Biol Blood Marrow Transplant; 2018 Apr; 24(4):741-750. PubMed ID: 29247779
[TBL] [Abstract][Full Text] [Related]
5. Long-term outcome of ph-negative acute lymphoblastic leukaemia in adults: a single centre experience.
Castagnola C; Lunghi M; Caberlon S; Bonfichi M; Pascutto C; Lazzarino M
Acta Haematol; 2005; 113(4):234-40. PubMed ID: 15983429
[TBL] [Abstract][Full Text] [Related]
6. The long-term results of childhood acute lymphoblastic leukemia at two centers from Turkey: 15 years of experience with the ALL-BFM 95 protocol.
Güneş AM; Oren H; Baytan B; Bengoa SY; Evim MS; Gözmen S; Tüfekçi O; Karapınar TH; Irken G
Ann Hematol; 2014 Oct; 93(10):1677-84. PubMed ID: 24863691
[TBL] [Abstract][Full Text] [Related]
7. Primary refractory and relapsed adult acute lymphoblastic leukemia: characteristics, treatment results, and prognosis with salvage therapy.
Thomas DA; Kantarjian H; Smith TL; Koller C; Cortes J; O'Brien S; Giles FJ; Gajewski J; Pierce S; Keating MJ
Cancer; 1999 Oct; 86(7):1216-30. PubMed ID: 10506707
[TBL] [Abstract][Full Text] [Related]
8. Long-term follow-up of imatinib plus combination chemotherapy in patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lim SN; Joo YD; Lee KH; Kim DY; Lee JH; Lee JH; Chi HS; Yun SC; Lee WS; Lee SM; Park S; Kim I; Sohn SK; Moon JH; Ryoo HM; Bae SH; Hyun MS; Kim MK; Kim HJ; Yang DH; Eom HS; Lee GW; Jung CW; Won JH; Kim H; Lee JH; Shin HJ; Jang DY
Am J Hematol; 2015 Nov; 90(11):1013-20. PubMed ID: 26228525
[TBL] [Abstract][Full Text] [Related]
9. Salvage therapy in refractory acute myeloid leukemia: prediction of outcome based on analysis of prognostic factors.
Tavernier E; Le QH; Elhamri M; Thomas X
Leuk Res; 2003 Mar; 27(3):205-14. PubMed ID: 12537972
[TBL] [Abstract][Full Text] [Related]
10. Induction therapy for adults with acute lymphoblastic leukemia: results of more than 1500 patients from the international ALL trial: MRC UKALL XII/ECOG E2993.
Rowe JM; Buck G; Burnett AK; Chopra R; Wiernik PH; Richards SM; Lazarus HM; Franklin IM; Litzow MR; Ciobanu N; Prentice HG; Durrant J; Tallman MS; Goldstone AH; ;
Blood; 2005 Dec; 106(12):3760-7. PubMed ID: 16105981
[TBL] [Abstract][Full Text] [Related]
11. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
[TBL] [Abstract][Full Text] [Related]
12. [Clinical study of Philadelphia chromosome-positive adult acute lymphoblastic leukemia].
Zhang YF; Chen ZM; Lou JY; Ni WM; Wang YG; Meng HT; Tong HY; Qian WB; Jin J
Zhonghua Xue Ye Xue Za Zhi; 2011 Dec; 32(12):814-8. PubMed ID: 22339953
[TBL] [Abstract][Full Text] [Related]
13. CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia.
Thomas X; Archimbaud E; Charrin C; Magaud JP; Fiere D
Leukemia; 1995 Feb; 9(2):249-53. PubMed ID: 7532767
[TBL] [Abstract][Full Text] [Related]
14. Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
Ribera JM; Ortega JJ; Oriol A; Fontanillas M; Hernández-Rivas JM; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel JF
Haematologica; 1998 Mar; 83(3):222-30. PubMed ID: 9573676
[TBL] [Abstract][Full Text] [Related]
15. High relapse rate of T cell acute lymphoblastic leukemia in adults treated with Hyper-CVAD chemotherapy in Sweden.
Kozlowski P; Åström M; Ahlberg L; Bernell P; Hulegårdh E; Hägglund H; Karlsson K; Markuszewska-Kuczymska A; Tomaszewska-Toporska B; Smedmyr B; Amini RM; Hallböök H;
Eur J Haematol; 2014; 92(5):377-81. PubMed ID: 24443846
[TBL] [Abstract][Full Text] [Related]
16. Philadelphia chromosome positive adult acute lymphoblastic leukemia: characteristics, prognostic factors and treatment outcome.
Thomas X; Thiebaut A; Olteanu N; Danaïla C; Charrin C; Archimbaud E; Fiere D
Hematol Cell Ther; 1998 Jun; 40(3):119-28. PubMed ID: 9698220
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and prognostic factors of imatinib plus CALLG2008 protocol in adult patients with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia.
Lou Y; Ma Y; Li C; Suo S; Tong H; Qian W; Mai W; Meng H; Yu W; Mao L; Wei J; Xu W; Jin J
Front Med; 2017 Jun; 11(2):229-238. PubMed ID: 28349299
[TBL] [Abstract][Full Text] [Related]
18. Clinical Outcomes of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia in a County Hospital System.
Apostolidou E; Lachowiez C; Juneja HS; Qiao W; Ononogbu O; Miller-Chism CN; Udden M; Ma H; Mims MP
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e895-e902. PubMed ID: 34376374
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetics Does Not Impact Outcomes in Adult Patients with Acute Lymphoblastic Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation.
Aldoss I; Tsai NC; Slovak ML; Palmer J; Alvarnas J; Marcucci G; Forman SJ; Pullarkat V
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1212-1217. PubMed ID: 27044907
[TBL] [Abstract][Full Text] [Related]
20. Philadelphia chromosome-positive acute lymphoblastic leukemia in the elderly: prognostic factors and treatment outcome.
Houot R; Tavernier E; Le QH; Lhéritier V; Thiebaut A; Thomas X
Hematology; 2004; 9(5-6):369-76. PubMed ID: 15763976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
